ÍøºìºÚÁÏ

Skip to main content
(352) 273-8740

Ali Ataya, MD : Research

Critical Care Medicine Specialist, Pulmonologist (Lung Specialist)

Photo of Ali Ataya
(352) 273-8740 MyUFÍøºìºÚÁÏ

Research at a glance

Top areas of exploration

  • Dyspnea , 10 publications
  • Pulmonary Alveolar Proteinosis , 4 publications
  • Lymphangioleiomyomatosis , 4 publications
  • Fever , 4 publications

Research activity

122 publications

396 citations

Why is this important?

Active clinical trials

Prosera

The primary objective of the study is to determine the effect of seralutinib on improving exercise capacity in subjects with WHO Group 1 PAH who are FC II or III. The secondary objective for this trial is to determine time to clinical worsening.

Investigator
Ali Ataya
Status
Accepting Candidates
Ages
18 Years - 75 Years
Sexes
All
Hemotag
Investigator
Ali Ataya
Status
Accepting Candidates
ROR-PH-303 (APD811-303)

Study ROR-PH-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants with WHO Group 1 PAH who have participated in another Phase 2 or Phase 3 study of ralinepag.

Investigator
Ali Ataya
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

122 publications

2024

A 35-Year-Old Woman With Placenta Previa and Postpartum Cardiovascular Collapse

CHEST

2024

A perfectly imperfect engine: Utilizing the digital twin paradigm in pulmonary hypertension

Pulmonary Circulation

2024

Abdominal pain in a patient with epistaxis, telangiectasias, and arteriovenous malformations.

Cleveland Clinic journal of medicine

•

2024

Autoimmune Pulmonary Alveolar Proteinosis: A Review of Pathogenesis and Emerging Therapies

Current Pulmonology Reports

2024

Comment on the European Respiratory Society pulmonary alveolar proteinosis guidelines.

The European respiratory journal

•